<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Bezafibrat.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:14 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="filelist-85.xml.html" tppabs="http://www.vietstarse.com/duocthu/Documents/Bezafibrat_files/filelist.xml">
<link rel=Edit-Time-Data href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Bezafibrat_files/editdata.mso  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Bezafibrat_files/editdata.mso'" tppabs="http://www.vietstarse.com/duocthu/Documents/Bezafibrat_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>BEZAFIBRAT</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>3</o:TotalTime>
  <o:Created>2006-08-08T14:01:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:20:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>713</o:Words>
  <o:Characters>4067</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>33</o:Lines>
  <o:Paragraphs>9</o:Paragraphs>
  <o:CharactersWithSpaces>4771</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>BEZAFIBRAT<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><b><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Tên chung qu&#7889;c t&#7871;:</span></b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>
Bezafibrate.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><b><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Mã ATC:</span></b><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> C10A B02.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><b><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Lo&#7841;i thu&#7889;c:</span></b><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> Thu&#7889;c h&#7841; lipid máu
(nhóm fibrat).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><b><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>D&#7841;ng thu&#7889;c và hàm l&#432;&#7907;ng</span></b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Viên nén ho&#7863;c viên bao &#273;&#432;&#7901;ng: 200
mg, 400 mg.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Bezafibrat, d&#7851;n ch&#7845;t c&#7911;a acid fibric, là
thu&#7889;c h&#7841; lipid máu. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Bezafibrat &#7913;c ch&#7871; sinh t&#7893;ng h&#7907;p
cholesterol &#7903; gan, tác d&#7909;ng chính là làm gi&#7843;m lipoprotein t&#7927;
tr&#7885;ng r&#7845;t th&#7845;p và lipoprotein t&#7927; tr&#7885;ng th&#7845;p
(VLDL và LDL) và làm t&#259;ng lipoprotein t&#7927; tr&#7885;ng cao (HDL). Do
&#273;ó thu&#7889;c c&#7843;i thi&#7879;n m&#7897;t cách &#273;áng k&#7875;
phân b&#7889; cholesterol trong huy&#7871;t t&#432;&#417;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Bezafibrat có kh&#7843; n&#259;ng làm h&#7841; cholesterol
máu và triglycerid máu nên &#273;&#432;&#7907;c dùng &#273;&#7875; &#273;i&#7873;u
tr&#7883; t&#259;ng lipid máu typ IIa, IIb, III, IV và V kèm theo ch&#7871;
&#273;&#7897; &#259;n r&#7845;t h&#7841;n ch&#7871; m&#7905;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Bezafibrat &#273;&#432;&#7907;c h&#7845;p th&#7909; &#7903;
&#273;&#432;&#7901;ng tiêu hóa khi u&#7889;ng trong b&#7919;a &#259;n,
nh&#432;ng s&#7921; h&#7845;p th&#7909; s&#7869; kém khi &#273;ói và b&#7883;
gi&#7843;m &#273;i r&#7845;t nhi&#7873;u n&#7871;u u&#7889;ng sau khi nh&#7883;n
&#273;ói qua &#273;êm. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Bezafibrat d&#7877; dàng b&#7883; th&#7911;y phân thành ch&#7845;t
chuy&#7875;n hóa có ho&#7841;t tính, liên k&#7871;t nhi&#7873;u v&#7899;i
albumin huy&#7871;t t&#432;&#417;ng, do &#273;ó &#273;&#7849;y các thu&#7889;c
kháng vitamin K ra kh&#7887;i v&#7883; trí g&#7855;n v&#7899;i protein huy&#7871;t
t&#432;&#417;ng c&#7911;a chúng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>N&#7891;ng &#273;&#7897; &#273;&#7881;nh huy&#7871;t
t&#432;&#417;ng &#273;&#7841;t &#273;&#432;&#7907;c trong vòng 2 &#273;&#7871;n
4 gi&#7901; sau khi u&#7889;ng thu&#7889;c. Trên 95% thu&#7889;c g&#7855;n v&#7899;i
protein huy&#7871;t t&#432;&#417;ng, g&#7847;n nh&#432; duy nh&#7845;t v&#7899;i
albumin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Th&#7875; tích phân b&#7889;: 0,2 lít/kg.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>N&#7917;a &#273;&#7901;i th&#7843;i tr&#7915;: 2,1 gi&#7901;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Thu&#7889;c &#273;&#432;&#7907;c phân b&#7889; r&#7897;ng
và t&#7853;p trung &#7903; gan, th&#7853;n và ru&#7897;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>60% &#273;&#7871;n 90% li&#7873;u u&#7889;ng th&#7843;i tr&#7915;
vào n&#432;&#7899;c ti&#7875;u và m&#7897;t ít vào phân, ch&#7911; y&#7871;u
d&#432;&#7899;i d&#7841;ng liên h&#7907;p glucuronic.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>T&#259;ng lipoprotein - máu typ IIa, IIb, III, IV và V &#7903;
ng&#432;&#7901;i không &#273;áp &#7913;ng t&#7889;t v&#7899;i ch&#7871; &#273;&#7897;
&#259;n và các bi&#7879;n pháp thích h&#7907;p khác.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Suy gi&#7843;m ch&#7913;c n&#259;ng gan n&#7863;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Suy th&#7853;n n&#7863;ng.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Ph&#7843;i th&#7853;n tr&#7885;ng khi dùng bezafibrat &#7903;
ng&#432;&#7901;i b&#7879;nh suy th&#7853;n. Khi có n&#7891;ng &#273;&#7897;
creatinin huy&#7871;t thanh t&#259;ng d&#7847;n ho&#7863;c khi không theo
&#273;úng li&#7873;u h&#432;&#7899;ng d&#7851;n, có th&#7875; d&#7851;n &#273;&#7871;n
phân gi&#7843;i c&#417; vân.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>N&#7871;u dùng cùng v&#7899;i cholestyramin thì ph&#7843;i
dùng cách 3 gi&#7901; gi&#7919;a li&#7873;u cholestyramin và li&#7873;u
bezafibrat.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Ng&#432;&#7901;i b&#7879;nh &#273;ang dùng thu&#7889;c ch&#7889;ng
&#273;ông máu, n&#7871;u c&#7847;n dùng bezafibrat, ph&#7843;i gi&#7843;m b&#7899;t
kho&#7843;ng 1/3 li&#7873;u thu&#7889;c ch&#7889;ng &#273;ông máu.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Không dùng ph&#7889;i h&#7907;p bezafibrat v&#7899;i các
thu&#7889;c có tác d&#7909;ng &#273;&#7897;c cho gan nh&#432; thu&#7889;c &#7913;c
ch&#7871; MAO, perhexilin.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Kinh nghi&#7879;m lâm sàng v&#7873; &#273;i&#7873;u tr&#7883;
cho ng&#432;&#7901;i mang thai còn r&#7845;t h&#7841;n ch&#7871;. Cho t&#7899;i
nay ch&#432;a có s&#7889; li&#7879;u nào ch&#7913;ng t&#7887; nguy c&#417; gây
quái thai. Tuy v&#7853;y, thu&#7889;c không &#273;&#432;&#7907;c khuy&#7871;n
cáo dùng cho ng&#432;&#7901;i mang thai, vì thi&#7871;u ch&#7913;ng c&#7913; an
toàn.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Không có s&#7889; li&#7879;u v&#7873; vi&#7879;c
bezafibrat bài ti&#7871;t qua s&#7919;a. Không khuy&#7871;n cáo dùng thu&#7889;c
này trong th&#7901;i k&#7923; cho con bú.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác
d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Các tác d&#7909;ng không mong mu&#7889;n c&#7911;a
bezafibrat t&#432;&#417;ng t&#7921; nh&#432; c&#7911;a các fibrat, th&#432;&#7901;ng
nh&#7865; ho&#7863;c không xu&#7845;t hi&#7879;n trong quá trình &#273;i&#7873;u
tr&#7883; ng&#7855;n. Các tác d&#7909;ng không mong mu&#7889;n trên h&#7879;
tiêu hóa là ch&#7911; y&#7871;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><i><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt;1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Tiêu hóa: R&#7889;i lo&#7841;n tiêu hóa, khó tiêu, bu&#7891;n
nôn và &#7881;a ch&#7843;y nh&#7865;.<i><o:p></o:p></i></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><i><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>H&#7879; th&#7847;n kinh trung &#432;&#417;ng: Ðau &#273;&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>Gan: T&#259;ng transaminase.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>Da: Mày &#273;ay.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>H&#7879; c&#417;,
x&#432;&#417;ng: Ðau nh&#7913;c c&#417;.<i><o:p></o:p></i></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><i><span lang=DE style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana;mso-ansi-language:DE'>Hi&#7871;m g&#7863;p,
ADR &lt; 1/1000<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>Máu: Gi&#7843;m hemoglobin, gi&#7843;m
ti&#7875;u c&#7847;u, gi&#7843;m b&#7841;ch c&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>Ch&#7913;c n&#259;ng sinh d&#7909;c:
M&#7845;t ham mu&#7889;n tình d&#7909;c và b&#7845;t l&#7921;c.<i><o:p></o:p></i></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>Trong tr&#432;&#7901;ng h&#7907;p
&#273;au nh&#7913;c c&#417; không rõ nguyên nhân thì ph&#7843;i ng&#7915;ng
&#273;i&#7873;u tr&#7883; v&#7899;i bezafibrat, và ti&#7871;n hành &#273;&#7883;nh
l&#432;&#7907;ng creatin kinase (CK) &#273;&#7875; &#273;i&#7873;u tra. <o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Li&#7873;u l&#432;&#7907;ng và cách
dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>Dùng bezafibrat theo
&#273;&#432;&#7901;ng u&#7889;ng và nh&#7845;t thi&#7871;t ph&#7843;i ph&#7889;i
h&#7907;p v&#7899;i ch&#7871; &#273;&#7897; &#259;n h&#7841;n ch&#7871; m&#7905;
và ph&#7843;i u&#7889;ng thu&#7889;c trong b&#7919;a &#259;n ho&#7863;c ngay
sau b&#7919;a &#259;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>Li&#7873;u thông th&#432;&#7901;ng
ng&#432;&#7901;i l&#7899;n:<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>Ngày u&#7889;ng 3 l&#7847;n, m&#7895;i
l&#7847;n 200 mg, vào b&#7919;a &#259;n ho&#7863;c ngay sau b&#7919;a &#259;n.
Có th&#7875; u&#7889;ng 400 mg m&#7897;t l&#7847;n m&#7895;i ngày vào b&#7919;a
&#259;n chính ho&#7863;c ngay sau b&#7919;a &#259;n chính (li&#7873;u 400 mg/1
l&#7847;n không thích h&#7907;p cho ng&#432;&#7901;i suy th&#7853;n).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>Ði&#7873;u tr&#7883; b&#7857;ng
bezafibrat ph&#7843;i k&#7871;t h&#7907;p v&#7899;i ki&#7875;m tra cholesterol
và triglycerid. N&#7871;u k&#7871;t qu&#7843; &#273;i&#7873;u tr&#7883; không
&#273;&#7841;t &#273;&#432;&#7907;c trong 3 - 4 tháng thì ph&#7843;i l&#7921;a
ch&#7885;n cách &#273;i&#7873;u tr&#7883; khác.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana;mso-ansi-language:DE'>Ði&#7873;u ch&#7881;nh li&#7873;u
theo ch&#7913;c n&#259;ng th&#7853;n (creatinin huy&#7871;t thanh):<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><!--[if gte vml 1]><o:wrapblock><v:shapetype id="_x0000_t75"
  coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
  filled="f" stroked="f">
  <v:stroke joinstyle="miter"/>
  <v:formulas>
   <v:f eqn="if lineDrawn pixelLineWidth 0"/>
   <v:f eqn="sum @0 1 0"/>
   <v:f eqn="sum 0 0 @1"/>
   <v:f eqn="prod @2 1 2"/>
   <v:f eqn="prod @3 21600 pixelWidth"/>
   <v:f eqn="prod @3 21600 pixelHeight"/>
   <v:f eqn="sum @0 0 1"/>
   <v:f eqn="prod @6 1 2"/>
   <v:f eqn="prod @7 21600 pixelWidth"/>
   <v:f eqn="sum @8 21600 0"/>
   <v:f eqn="prod @7 21600 pixelHeight"/>
   <v:f eqn="sum @10 21600 0"/>
  </v:formulas>
  <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
  <o:lock v:ext="edit" aspectratio="t"/>
 </v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" style='position:absolute;
  margin-left:27pt;margin-top:0;width:202.5pt;height:123pt;z-index:1'>
  <v:imagedata src="Bezafibrat_files/image001.png" o:title=""/>
  <w:wrap type="topAndBottom"/>
 </v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=36 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=270 height=164 src="image002-9.jpg" tppabs="http://www.vietstarse.com/duocthu/Documents/Bezafibrat_files/image002.jpg" v:shapes="_x0000_s1026"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'><o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>N&#7871;u u&#7889;ng bezafibrat cùng v&#7899;i
cholestyramin thì ph&#7843;i dùng cách 3 gi&#7901; gi&#7919;a li&#7873;u
cholestyramin và li&#7873;u bezafibrat.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng
tác thu&#7889;c<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Các thu&#7889;c fibrat dùng k&#7871;t h&#7907;p v&#7899;i
các thu&#7889;c &#7913;c ch&#7871; HMG CoA reductase (ví d&#7909;: pravastatin,
fluvastatin) s&#7869; làm t&#259;ng nhi&#7873;u nguy c&#417; t&#7893;n
th&#432;&#417;ng c&#417; và viêm t&#7909;y c&#7845;p.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Bezafibrat k&#7871;t h&#7907;p v&#7899;i cyclosporin làm
t&#259;ng nguy c&#417; t&#7893;n th&#432;&#417;ng c&#417;. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Thu&#7889;c làm t&#259;ng tác d&#7909;ng c&#7911;a thu&#7889;c
ch&#7889;ng &#273;ông máu d&#7841;ng u&#7889;ng, do &#273;ó t&#259;ng nguy
c&#417; xu&#7845;t huy&#7871;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Bezafibrat t&#432;&#417;ng tác v&#7899;i các thu&#7889;c g&#7855;n
vào acid m&#7853;t nh&#432; cholestyramin, colestipol, và làm gi&#7843;m h&#7845;p
th&#7909; bezafibrat.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897;
&#7893;n &#273;&#7883;nh và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>B&#7843;o qu&#7843;n tránh &#7849;m.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Quá
li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Quá li&#7873;u bezafibrat có th&#7875; gây suy th&#7853;n
n&#7863;ng h&#7891;i ph&#7909;c &#273;&#432;&#7907;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Ði&#7873;u tr&#7883; quá li&#7873;u các thu&#7889;c h&#7841;
lipid máu th&#432;&#7901;ng là &#273;i&#7873;u tr&#7883; tri&#7879;u ch&#7913;ng
và &#273;i&#7873;u tr&#7883; h&#7895; tr&#7907;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%;
tab-stops:35.45pt'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Không có thu&#7889;c gi&#7843;i &#273;&#7897;c.<o:p></o:p></span></p>

<p class=cach0 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thông
tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
&#273;&#7897;c b&#7843;ng B.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thành ph&#7849;m
gi&#7843;m &#273;&#7897;c: Thu&#7889;c viên có hàm l&#432;&#7907;ng t&#7889;i
&#273;a là 200 mg.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Bezafibrat.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:17 GMT -->
</html>
